microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer
about
Differential oestrogen receptor binding is associated with clinical outcome in breast cancerMiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerIntegrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potentialMicroRNAs in breast cancer initiation and progressionMicroRNA profiling: approaches and considerationsMicroRNAs and triple negative breast cancerHypoxamiRs and cancer: from biology to targeted therapyThe miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identityMicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potentialDistinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcomeNovel genes associated with lymph node metastasis in triple negative breast cancerThe miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancerGATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression.Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they controlInvestigation of key microRNAs associated with hepatocellular carcinoma using small RNA-seq data.MVDA: a multi-view genomic data integration methodology.miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets.Multiple functions of hypoxia-regulated miR-210 in cancer.MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysisA prognostic model of triple-negative breast cancer based on miR-27b-3p and node statusIn vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer.Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosisTargeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasisMicroRNAs discriminate familial from sporadic non-BRCA1/2 breast carcinoma arising in patients ≤35 years.COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatmentIntegrated analysis of microRNA-target interactions with clinical outcomes for cancersPrognostic value of miR-221-3p, miR-342-3p and miR-491-5p expression in colon cancerHITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancerRegulation of the mRNA half-life in breast cancerIncreased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans.SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors.MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor statusAge-specific changes in intrinsic breast cancer subtypes: a focus on older womenIntegrative investigation on breast cancer in ER, PR and HER2-defined subgroups using mRNA and miRNA expression profiling.Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populations.The regulatory effect of miRNAs is a heritable genetic trait in humans.Comprehensive analysis of microRNAs in breast cancerHigh-throughput validation of ceRNA regulatory networksmiR-506 regulates epithelial mesenchymal transition in breast cancer cell lines.
P2860
Q24595511-570E61C8-D3BC-4218-A6AD-CD4063B6A6A4Q26775086-C7F2F5BF-6E21-40A1-87AD-F5F2A97766B4Q26782613-EFAD57C8-662F-4250-8E33-A2A8B98ACD77Q26823360-145C3DC6-E93E-4B9E-B565-7D2A43A2B922Q26861675-3F481B7F-BB46-4736-9614-C3D4A5760D2CQ26862716-CDA71E99-7DDF-4142-BF29-7B23BA07E123Q26863298-54DE38BA-BF79-4B53-950F-C32813FDDEFEQ27010233-89134FA3-BA13-4E96-ACEE-2507DB4A8713Q28081081-A1C8AD07-75F4-44CF-8406-768A5A0ACFA5Q28273187-7FF42F46-0173-427F-8E56-AF309A81ED9EQ28393204-187067B6-FBFF-414D-A491-3CEF1C89DF47Q28468629-111EB3DB-3141-47C4-AE64-06BE8AF05377Q30540007-A58E7A63-DACF-40A3-8153-71407F511D65Q30577477-6092FA25-EE13-4AA9-82F9-749DDD35B0CCQ30776344-60B7C733-C0F1-4F57-95AB-8BD91B91D07FQ30987838-24802276-2EEC-4F0D-AC17-3E979B36793FQ31136911-2FA721CF-B5B8-4887-B7D6-782C6719E3A2Q33741864-F97F9C57-7615-4DB8-A720-FA62846A1509Q33765128-DBFF9E93-D875-4D62-B0ED-F9229C968906Q33765619-1C611AF6-2AD9-4F10-BD40-78CF790614C8Q33779774-FAD014E0-D956-4A47-9559-755222CFD9A8Q33805335-94D49C4E-FFEC-49F5-99A7-F4BACEACB152Q33821114-A109FCFD-4BC9-4BC0-94B0-86D1A7635B57Q33829745-3FEB6633-A8E4-4B4E-8E6C-FB1994398665Q33875195-F92674C1-BCC9-4659-BA1F-C947A5850240Q33877411-FEFC2A17-201E-4CD7-9616-CE6B426843C6Q33912418-B2865D7D-0007-4848-9DB0-14BE29527CCBQ33961980-41B99E02-654A-419D-B70A-8789165D7A07Q33970563-C51BC379-843E-4289-A267-31D51F5A9679Q34023658-A749A0DC-30CA-4113-978B-3E02D84167B3Q34171160-24078894-009E-4B84-A7B0-4EFA2816D5BDQ34288454-8BE5DE1A-8DEC-4256-9778-3F83B31C276AQ34314082-33B2CC41-B8D9-4688-B1FC-68C71D2B673BQ34359310-2F4B5B22-8C26-4194-A922-034B13E25B11Q34390516-B61932BE-54B3-4078-BDEE-B1FE56DB3A36Q34485047-4D0A20B1-5E54-482F-A704-9717561B4D25Q34526435-0FE1461E-CDA2-4CE5-8327-378A73B4ADB4Q34529730-A8F93F99-1945-43DE-B257-1EC278011981Q34557271-19D6B8C1-A8EB-4BB9-B75E-7BFF81919DBBQ34745553-08847BFA-61E9-428E-AD7A-0951467E7075
P2860
microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer
description
im Juli 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 07 July 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2011
@uk
name
microRNA-Associated Progressio ...... ion Profiling in Breast Cancer
@en
microRNA-Associated Progressio ...... ion Profiling in Breast Cancer
@nl
type
label
microRNA-Associated Progressio ...... ion Profiling in Breast Cancer
@en
microRNA-Associated Progressio ...... ion Profiling in Breast Cancer
@nl
prefLabel
microRNA-Associated Progressio ...... ion Profiling in Breast Cancer
@en
microRNA-Associated Progressio ...... ion Profiling in Breast Cancer
@nl
P2093
P50
P1433
P1476
microRNA-associated progressio ...... ion profiling in breast cancer
@en
P2093
Carme Camps
Francesca M Buffa
Helen Sheldon
Jiannis Ragoussis
Laura Winchester
Marian Taylor
P304
P356
10.1158/0008-5472.CAN-11-0489
P407
P577
2011-07-07T00:00:00Z